Biological E
-
Takeda, Biological E collaborate for dengue vaccine in endemic areas
Biological E to manufacture up to 50 million doses of QDENGA Per Year Takeda and Biological E announced a strategic…
Read More » -
CORBEVAX gets DCGI nod as heterologous COVID-19 booster dose
People who are 18 years and above and have already taken two doses of either COVISHIELD or COVAXIN can now…
Read More » -
FABA presents awards to contributors in bio technology
Dr BS Bajaj Memorial Award has been awarded to Mahima Datla and FABA Lifetime Achievement Award to BP Acharya Federation…
Read More » -
Biological E’s CORBEVAX receives DCGI approval for clinical trials
Phase II/III paediatric trials will be conducted in children and adolescents The Department of Biotechnology (DBT) and its PSU, Biotechnology…
Read More » -
India seeks funds from Quad alliance to match China’s vaccine push: Source
India has urged the US, Japan and Australia to invest in its vaccine production capacity India has urged the US,…
Read More » -
CEPI to help fund Biological E’s COVID-19 vaccine
CEPI will contribute an initial amount of up to $5 million and will consider providing more funding to help produce…
Read More »